Ahmed El Haidani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmed El Haidani has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Nadia Lahrach
Team of Ethnopharmacology and Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University of Meknes, Errachidia 50000, Morocco
3 shared publications - Abdelhadi Elhasnaoui
Ethnopharmacology and Pharmacognosy Team, Faculty of Sciences and Technics Errachidia, Moulay Ismaïl University of Meknes, 509 Boutalamine, Errachidia 52000, Morocco
2 shared publications - Ayoub Amssayef
Department of Biology, Faculty of Sciences Dhar El Mahraz, Sidi Mohammed Ben Abdellah University, Fez 3 003, Morocco
2 shared publications - Iman Janah
Laboratory of Agro-Food, Biotechnologies and Valorization of Plant Bioresources, Department of Biology, Faculty of Science Semlalia, Cadi Ayyad University, Marrakesh 40000, Morocco
2 shared publications - Mohamed Eddouks
Team of Ethnopharmacology and Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University of Meknes, Errachidia, Morocco
2 shared publications - Saad Ibnsouda Koraichi
Laboratoire de Biotechnologie Microbienne et Molécules Bioactives, Faculté des Sciences et Techniques, Université Sidi Mohamed Ben Abdellah, Université Sidi Mohamed Ben Abdellah-Fès, Fès, Morocco
2 shared publications
Latest Publications
- Open Access
- 10 May 2025
- Published by Horizon E-Publishing Group in Plant Science Today
Antioxidant and antimicrobial potentials of Matricaria pubescens from the southeastern Morocco
This study explores the antioxidant and antimicrobial properties of Matricaria pubescens (Desf) Schultz, an aromatic plant traditionally used in Moroccan medicine. Collected from Errachidia, extracts were prepared using water, methanol and petroleum ether to assess polyphenol, flavonoid and tannin contents. Antioxidant capacity was evaluated via DPPH, ABTS and RPC assays, while antimicrobial activity was tested against six microbial strains using disc diffusion and microdilution methods. The methanolic extract exhibited the highest bioactivity, with inhibition zones of 16 mm (Staphylococcus aureus), 18 mm (Bacillus subtilis subsp. spizizenii), 10 mm (Escherichia coli), 12 mm (Salmonella abony), 14 mm (Candida albicans) and 12 mm (Trichophyton rubrum). Bacillus subtilis subsp. spizizenii and Staphylococcus aureus were the most sensitive (MIC: 1.87 and 3.75 mg/mL), while antifungal activity was observed against Candida albicans (7.5 mg/mL) and Trichophyton rubrum (15 mg/mL). These findings highlight the significant antimicrobial potential of M. pubescens, reinforcing its pharmaceutical value and encouraging further investigation into its bioactive compounds.
- 10 May 2025
- Published by Horizon E-Publishing Group in Plant Science Today
Open AccessAntioxidant and antimicrobial potentials of Matricaria pubescens from the southeastern Morocco
This study explores the antioxidant and antimicrobial properties of Matricaria pubescens (Desf) Schultz, an aromatic plant traditionally used in Moroccan medicine. Collected from Errachidia, extracts were prepared using water, methanol and petroleum ether to assess polyphenol, flavonoid and tannin contents. Antioxidant capacity was evaluated via DPPH, ABTS and RPC assays, while antimicrobial activity was tested against six microbial strains using disc diffusion and microdilution methods. The methanolic extract exhibited the highest bioactivity, with inhibition zones of 16 mm (Staphylococcus aureus), 18 mm (Bacillus subtilis subsp. spizizenii), 10 mm (Escherichia coli), 12 mm (Salmonella abony), 14 mm (Candida albicans) and 12 mm (Trichophyton rubrum). Bacillus subtilis subsp. spizizenii and Staphylococcus aureus were the most sensitive (MIC: 1.87 and 3.75 mg/mL), while antifungal activity was observed against Candida albicans (7.5 mg/mL) and Trichophyton rubrum (15 mg/mL). These findings highlight the significant antimicrobial potential of M. pubescens, reinforcing its pharmaceutical value and encouraging further investigation into its bioactive compounds.
- Open Access
- 3 June 2024
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 11, 171-183
Ethnopharmacological survey of medicinal plants used in traditional treatment of respiratory system disorders in the Southeast region of Morocco
The use of medicinal plants in primary healthcare in Africa, especially among populations in developing countries, is a common practice. To identify the most commonly used medicinal plants in traditional medicine for treating common respiratory disorders, an ethnobotanical survey was conducted in the Draa Tafilalet region, South-Eastern Morocco, involving 235 herbalists and sellers of medicinal plants from three provinces (Errachidia, Tinghir, and Zagora). Ethnobotanical data were evaluated using use value (UV), frequency of citation (FC), relative frequency of citation (RFC), and family importance value (FIV). The survey identified a total of 76 species belonging to 39 families, with the most represented being Lamiaceae, Apiaceae, and Asteraceae, followed by Fabaceae. As for the most commonly used species against respiratory disorders, they include Origanum vulgare L. (UV = 0.413), Artemisia herba-alba (UV = 0.370), Foeniculum vulgare (UV = 0.357), Thymus vulgaris (UV = 0.332), Lavandula dentata (UV = 0.319), Matricaria chamomilla (UV = 0.311), Nigella sativa (UV = 0.302), Allium sativum L. (UV = 0.298), Eucalyptus globulus (UV = 0.289), and Plantago major L. (UV= 0.281). Decoction (48.68%) and infusion (47.37%) are the most recommended preparation methods by herbalists for remedies. Leaves are the most prescribed part, while the majority of plants are exclusively administered orally (92.11%). This ethnobotanical survey holds the potential to aid scientists and researchers in identifying plants that treat common respiratory disorders, potentially invaluable for the development of novel drugs.
- 3 June 2024
- Published by Horizon E-Publishing Group in Plant Science Today
- Vol. 11, 171-183
Open AccessEthnopharmacological survey of medicinal plants used in traditional treatment of respiratory system disorders in the Southeast region of Morocco
The use of medicinal plants in primary healthcare in Africa, especially among populations in developing countries, is a common practice. To identify the most commonly used medicinal plants in traditional medicine for treating common respiratory disorders, an ethnobotanical survey was conducted in the Draa Tafilalet region, South-Eastern Morocco, involving 235 herbalists and sellers of medicinal plants from three provinces (Errachidia, Tinghir, and Zagora). Ethnobotanical data were evaluated using use value (UV), frequency of citation (FC), relative frequency of citation (RFC), and family importance value (FIV). The survey identified a total of 76 species belonging to 39 families, with the most represented being Lamiaceae, Apiaceae, and Asteraceae, followed by Fabaceae. As for the most commonly used species against respiratory disorders, they include Origanum vulgare L. (UV = 0.413), Artemisia herba-alba (UV = 0.370), Foeniculum vulgare (UV = 0.357), Thymus vulgaris (UV = 0.332), Lavandula dentata (UV = 0.319), Matricaria chamomilla (UV = 0.311), Nigella sativa (UV = 0.302), Allium sativum L. (UV = 0.298), Eucalyptus globulus (UV = 0.289), and Plantago major L. (UV= 0.281). Decoction (48.68%) and infusion (47.37%) are the most recommended preparation methods by herbalists for remedies. Leaves are the most prescribed part, while the majority of plants are exclusively administered orally (92.11%). This ethnobotanical survey holds the potential to aid scientists and researchers in identifying plants that treat common respiratory disorders, potentially invaluable for the development of novel drugs.
- 1 March 2023
- Published by Bentham Science Publishers Ltd. in Cardiovascular & Hematological Disorders-Drug Targets
- Vol. 23 (1) , 50-63
Antidiabetic and Antidyslipidemic Effects of Artemisia mesatlantica, an Endemic Plant from Morocco
Aims: The study aimed to assess the antihyperglycemic and antidyslipidemic activities of Artemisia mesatlantica. Background: Artemisia mesatlantica is an endemic plant of Morocco used in traditional medicine as an alternative treatment for diabetes. Objective: The study was designed to examine the antihyperglycemic and antidyslipidemicability of aqueous extract of Artemisia mesatlantica (AMAE) in experimental animal models. Methods: The effect of the single and repeated oral administration (7 days of treatment) of AMAE (60 mg/kg) on blood glucose and lipid profile were assessed in normal and streptozotocin-induced diabetic rats. Furthermore, to confirm the antidyslipidemic effect of Artemisia mesatlantica, a model of hyperlipidemia induced by tyloxapol (Triton WR-1339) in rats was used. Results: The AMAE (60 mg/kg) was able to significantly reduce glycaemia, improve lipid profile and increase hepatic glycogen content in STZ-induced diabetic rats. In addition, pretreatment of rats for 7 consecutive days with an aqueous extract of Artemisia mesatlantica (600 mg/kg) prior to tyloxapol injection prevented increases in plasma levels of total cholesterol, triglycerides and LDL-c. Conclusion: From these observed results, it can be deduced that Artemisia mesatlantica possesses remarkable antidiabetic and antihyperlipidemic properties.
- 1 March 2023
- Published by Bentham Science Publishers Ltd. in Cardiovascular & Hematological Disorders-Drug Targets
- Vol. 23 (1) , 50-63
Antidiabetic and Antidyslipidemic Effects of Artemisia mesatlantica, an Endemic Plant from Morocco
Aims: The study aimed to assess the antihyperglycemic and antidyslipidemic activities of Artemisia mesatlantica. Background: Artemisia mesatlantica is an endemic plant of Morocco used in traditional medicine as an alternative treatment for diabetes. Objective: The study was designed to examine the antihyperglycemic and antidyslipidemicability of aqueous extract of Artemisia mesatlantica (AMAE) in experimental animal models. Methods: The effect of the single and repeated oral administration (7 days of treatment) of AMAE (60 mg/kg) on blood glucose and lipid profile were assessed in normal and streptozotocin-induced diabetic rats. Furthermore, to confirm the antidyslipidemic effect of Artemisia mesatlantica, a model of hyperlipidemia induced by tyloxapol (Triton WR-1339) in rats was used. Results: The AMAE (60 mg/kg) was able to significantly reduce glycaemia, improve lipid profile and increase hepatic glycogen content in STZ-induced diabetic rats. In addition, pretreatment of rats for 7 consecutive days with an aqueous extract of Artemisia mesatlantica (600 mg/kg) prior to tyloxapol injection prevented increases in plasma levels of total cholesterol, triglycerides and LDL-c. Conclusion: From these observed results, it can be deduced that Artemisia mesatlantica possesses remarkable antidiabetic and antihyperlipidemic properties.
- 1 June 2007
- Published by Springer Nature in Annals of Microbiology
- Vol. 57 (2) , 143-147
Yeast strains from the endogenous microflora of the olive fliesBactrocera oleae larvae which could degrade the olive oil mill wastewaters polyphenols
- 1 June 2007
- Published by Springer Nature in Annals of Microbiology
- Vol. 57 (2) , 143-147
Yeast strains from the endogenous microflora of the olive fliesBactrocera oleae larvae which could degrade the olive oil mill wastewaters polyphenols